Comparison Chart: Interleukin (IL) Antagonists and Oral JAK Inhibitors for Moderate to Severe Atopic Dermatitis (online only)

The Medical Letter on Drugs and Therapeutics

ONLINE
ONLY
ARTICLE

March 2, 2026

View Complete Issue Table of Contents 2019

Download PDF: US English

Show Related Terms Hide Related Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2026 Mar 2;68(1749):e43-4 doi:10.58347/tml.2026.1749e

Disclosures

Objective(s)

Select a term to see related articles abrocitinib Adbry atopic dermatitis Cibinqo dupilumab Dupixent Ebglyss lebrikizumab Nemluvio nemolizumab Rinvoq tralokinumab upadacitinib

View the Comparison Chart: Interleukin (IL) Antagonists and Oral JAK Inhibitors for Moderate to Severe Atopic Dermatitis

Download PDF: US English

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.